logo

Biotechnology & Drugs News

Share

Pfizer Announces Positive Top-line Results From Phase 3 Study Of PREVNAR 20

Deltex Medical Group FY Revenues £2.3 Mln Vs £2.4 Mln Last Year

Dechra Pharma Agrees Terms With Anivive Lifesciences To Buy Worldwide Rights To Verdinexor For Dogs